Dogwood Therapeutics, Inc. (DWTX)

NASDAQ: DWTX · Real-Time Price · USD

4.250

+0.070 (1.67%)

At close: Apr 4, 2025, 4:00 PM

4.240

-0.010 (-0.24%)

After-hours: Apr 4, 2025, 7:52 PM EDT

Dogwood Therapeutics Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2018 - 2019
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2018 - 2019
Net Income	-	-5.3	-12.25	-15.96	-10.35	Upgrade
Other Amortization	-	-	-	-	0.05	Upgrade
Stock-Based Compensation	-	0.62	0.58	0.32	7.43	Upgrade
Provision & Write-off of Bad Debts	-	-	-	-	-0.02	Upgrade
Other Operating Activities	-	-	-	-	-0.04	Upgrade
Change in Accounts Payable	-	-0.46	0.22	0.27	0.05	Upgrade
Change in Other Net Operating Assets	-	0.27	-0.02	-0.32	-1.03	Upgrade
Operating Cash Flow	-	-4.87	-11.47	-15.69	-3.9	Upgrade
Long-Term Debt Issued	-	-	-	-	1.99	Upgrade
Net Debt Issued (Repaid)	-	-	-	-	1.99	Upgrade
Issuance of Common Stock	-	1.16	4.49	0.2	31.53	Upgrade
Other Financing Activities	-	-	-	-0.3	-0.06	Upgrade
Financing Cash Flow	-	1.16	4.49	-0.1	33.38	Upgrade
Net Cash Flow	-	-3.71	-6.98	-15.79	29.49	Upgrade
Cash Interest Paid	-	-	-	-	0.01	Upgrade
Levered Free Cash Flow	-	-2.98	-6.92	-9.8	-0.77	Upgrade
Unlevered Free Cash Flow	-	-2.98	-6.92	-9.8	-0.53	Upgrade
Change in Net Working Capital	-1.92	0.19	-0.2	0.35	1.76	Upgrade

Updated Mar 14, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q